PSA Can Predicts The Treatment Response In Advanced Prostate Cancer
ped below 4.0 but above 0.2 lived 44 months and those whose PSA was un...The men in the study were enrolled in a Phase III SWOG trial in wh...A PSA test measures the level in the blood of prostate specific an...“What is attractive about using PSA to predict survival in metasta...Source: EurekAlrt....
ped below 4.0 but above 0.2 lived 44 months and those whose PSA was undetectable, below 0.2 ng/ml, lived 75 months.
The men in the study were enrolled in a Phase III SWOG trial in which they would receive additional treatment after the seven months of initial hormone therapy. That study seeks to accrue 1,512 men. The patient's PSA level before beginning treatment must be at least 5.0 ng/ml to qualify for the study.
A PSA test measures the level in the blood of prostate specific antigen, an enzyme produced by the prostate gland. It is generally used as an initial screening test to detect prostate cancer.
“What is attractive about using PSA to predict survival in metastatic prostate cancer is that it is an easily measurable factor. These findings could help patients avoid ineffective treatment and could help researchers design further trials,” Hussain says.